TX Tyler의 크론병 임상 시험
크론병 관련 연구 16개가 Tyler 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
피험자 모집 중3상
- Tyler Research Institute ( Site 0294), Tyler
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
피험자 모집 중3상
- Tyler Research Institute ( Site 5001), Tyler
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
피험자 모집 중3상
- Tyler Research Institute, Tyler
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
피험자 모집 중2상
- Tyler Research Institute, LLC, Tyler
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
피험자 모집 중2/3상
- Tyler Research Institute, LLC, Tyler
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
피험자 모집 중3상
- Tyler Research Institute, LLC, Tyler
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
피험자 모집 중3상
- The University of Texas Health Science Center at Tyler, Tyler
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
피험자 모집 중2상
- Tyler Research Institute, LLC, Tyler
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
피험자 모집 중2상
- Tyler Research Institute /ID# 284247, Tyler
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
피험자 모집 중3상
- Tyler Research Institute LLC-Site Number: 8400095, Tyler
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
피험자 모집 중3상
- Tyler Research Institute, LLC-Site Number: 8400095, Tyler
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
피험자 모집 중2상
- Tyler Research Institute /ID# 265545, Tyler
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
피험자 모집 중3상
- Tyler Research Institute, LLC, Tyler
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
피험자 모집 중2상
- Tyler Research Institute, LLC, Tyler
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
피험자 모집 중2상
- Tyler Research Institute, LLC, Tyler
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
피험자 모집 중2상
- Mirador Therapeutics Selected Site, Tyler
다른 도시의 크론병 시험
- New York City, NY연구 33개
- St. Louis, MO연구 19개
- Miami, FL연구 19개
- Orlando, FL연구 19개
- Boston, MA연구 18개
- Houston, TX연구 17개
- Atlanta, GA연구 16개
- San Diego, CA연구 15개
- Cleveland, OH연구 15개
- Colorado Springs, CO연구 14개
- San Antonio, TX연구 14개
- Los Angeles, CA연구 13개
Tyler의 다른 연구
- 비소세포폐암연구 19개
- 궤양성 대장염연구 13개
- 난소암연구 9개
- 대장직장암연구 8개
- 심부전연구 8개
- 암 (전체)연구 7개
- 두경부 편평세포암연구 6개
- 자궁내막암연구 6개
- 심방세동연구 6개
- 유방암연구 5개
- 전이성 암연구 5개
- 소세포 폐암연구 5개
ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.